Taking a candidate drug to market – and to the patients who will benefit from it – requires supporting data from high-volume, regulated clinical studies. From sample receipt to final reporting, Q2
Solutions understands the importance of delivering qualified clinical sample data throughout all stages of the drug development cycle. Our bioanalytical experts can partner with you to develop assays that incorporate state-of-the-art instrumentation, rigorous quality control, and a logistics infrastructure to support large-scale, international studies.
Download our factsheet to learn more about our ability to support large-scale clinical projects.